This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Respiratory Syncytial Virus Infections: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Respiratory Syncytial Virus Infections shares some biological mechanisms with asthma, bronchiolitis, bronchiolitis-viral, infective-disorder, inflammation, influenza, lower-respiratory-tract-infection, lung-diseases, nasopharyngeal-diseases, paramyxoviridae-infections, pneumonia, pneumonia-viral, respiration-disorders, respiratory-syncytial-virus-(rsv)-infection-in-conditions-classified-elsewhere-and-of-unspecified-site, respiratory-tract-diseases, respiratory-tract-infections, respirovirus-infections, virus-diseases, wheezing.
Among the many pathways, these few ones have gauged particular interests from scientists studying Respiratory Syncytial Virus Infections, and have been seen in publications frequently: Adaptive Immune Response, Cell Activation, Cell Death, Cytokine Production, Excretion, Glycosylation, Humoral Immune Response, Hypersensitivity, Immune Response, Inflammatory Response, Innate Immune Response, Localization, Pathogenesis, Reverse Transcription, Rna Interference, Secretion, Sensitization, Transport, Viral Replication, Virulence
Quite a number of genes have been found to play important roles in Respiratory Syncytial Virus Infections, such as ATP6V0A2, CCL2, CCL5, CD4, CD8A, GPHA2, IFNG, IL10, IL13, IL2, IL4, IL5, IL6, RNASE3, SGCA, TLR4, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.